Clinical trial Recruiting at 1 site Phase2; Phase3 Interventional Ages 18 and up

Using inhaled nitroglycerin to improve breathing in late-stage COPD patients

Official title: "The Effect of Inhaled Nitroglycerin on Improving Respiratory Failure in COPD Patients Admitted to Adult Intensive Care Unit"

Run by Beni-Suef University · NCT06785337 · Data updated 2026-11-12

This study is testing if inhaled nitroglycerin can help people with late-stage COPD breathe better and improve their lung function.

Quick facts

PhasePhase2; Phase3
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorBeni-Suef University
Academic / other
Locations1 site (Haram, Giza Governorate)
StatusRecruiting
StartedFebruary 1, 2025
Main results expectedOctober 1, 2025
Study endsDecember 1, 2025
Registry record updatedJanuary 23, 2025
Trial IDNCT06785337 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with COPD exacerbation and evidence of pulmonary hypertension.

Probably not a fit

Patients with profound left ventricular failure, pregnant women, or those with hypersensitivity to nitroglycerin may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of nebulized nitroglycerin on respiratory function in patients with late-stage Chronic Obstructive Pulmonary Disease (COPD). The approach focuses on the vasodilation of pulmonary arteries and arterioles, which can alleviate ventilation/perfusion mismatching that exacerbates COPD symptoms. Additionally, the study aims to enhance antibiotic delivery to the alveoli, potentially improving infection control in these patients. It is designed as an interventional study, encompassing both Phase 2 and Phase 3 evaluations.

Why it matters

Potential benefit: If successful, this treatment could significantly improve respiratory function and quality of life for patients with severe COPD.

How similar studies have gone: While the use of inhaled nitroglycerin is a novel approach in this context, similar studies have shown promise in improving respiratory outcomes in other conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patient's ≥ 18 years old COPD exacerbation with respiratory failure and Echo evidenced presence of pulmonary hypertension (defined as mean pulmonary artery pressure \> 20 mmHg)

Exclusion Criteria:

* Profound left ventricular failure, as the decrease in pulmonary vascular resistance results in an increase in left ventricular preload. This may worsen cardiogenic pulmonary edema.
* Pregnant female patients
* Patient with hypersensitivity to nitroglycerin

Where it's running

  • Haram Hospital
    Haram, Giza Governorate, Egypt
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer

    This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.

    Recruiting Phase 2 AeroRx Therapeutics Inc. · London and 1 other locations · NCT07896252

  • Cognitive load and inhaler technique in COPD

    This study tests whether adding a short memory task while using an inhaler makes COPD patients more likely to misuse their inhaler.

    Recruiting Spitalul Clinic de Boli Infecțioase și Pneumoftiziologie Dr. Victor Babeș Timișoara · Timișoara, Timiș County · NCT07786220

  • Balance training after pulmonary rehab for COPD to help steadiness and reduce falls

    A COPD-focused balance training program called Sport4Steadiness is being tested to see if people with COPD will accept it and if the study processes work well.

    Recruiting at 3 sites Teesside University · Middlesbrough and 2 other locations · NCT07750821

  • Continuous vs High-Intensity Interval Exercise in COPD

    This study tests whether continuous versus high-intensity interval exercise affects cerebral oxygenation in people with COPD.

    Recruiting George Papanicolaou Hospital · Thessaloniki, Exohi · NCT07707271

  • Biomarker clues for COPD, IPF, and lung cancer

    This study tests whether inflammation, immune, genetic, and epigenetic markers at enrollment can explain how COPD, IPF, or lung cancer present and behave, in order to see if these markers can predict outcomes over a year.

    Recruiting Fondazione Don Carlo Gnocchi ETS · Milan, Milan · NCT07707245

  • HRS-9821 Inhalation Suspension for COPD: Safety and Dose Finding in Adults

    This study tests whether HRS-9821 inhalation can be safely taken and help people with moderate to severe COPD, and aims to find a reasonable dose.

    Recruiting Phase 2 Guangdong Hengrui Pharmaceutical Co., Ltd · Shanghai, Shanghai Municipality · NCT07640451

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.